Hasil Pencarian - Alexander Fossa

Perbaiki Hasil
  1. 1
    Late-effect awareness and follow-up of cancer in general practice

    Late-effect awareness and follow-up of cancer in general practice oleh Siri A. Eikeland, Knut B. Smeland, Mette Brekke, Cecilie E. Kiserud, Alexander Fosså

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Controversies in the Treatment of Classical Hodgkin Lymphoma

    Controversies in the Treatment of Classical Hodgkin Lymphoma oleh Dennis A. Eichenauer, Marc André, Peter Johnson, Alexander Fossa, Olivier Casasnovas, Andreas Engert

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen

    Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen oleh Arne Kolstad, Harald Holte, Alexander Fosså, Grete Fossum Lauritzsen, Peter Gaustad, Dag Torfoss

    Diterbitkan 2007-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.

    Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years. oleh Dlawer Abdulla Barzenje, Milada Cvancarova Småstuen, Knut Liestøl, Alexander Fosså, Jan Delabie, Arne Kolstad, Harald Holte

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered

    The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered oleh Peter Borchmann, Alexander Fosså, Monika Długosz-Danecka, Boris Böll, Markus Dietlein, Carsten Kobe, Helen Goergen, Andreas Engert

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Distressed personality is associated with late adverse effects in long-term survivors of Hodgkin lymphoma

    Distressed personality is associated with late adverse effects in long-term survivors of Hodgkin lymphoma oleh Alv A. Dahl, Knut B. Smeland, Siri Eikeland, Unn-Merete Fagerli, Hanne S. Bersvendsen, Alexander Fosså, Cecilie E. Kiserud

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue.

    Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue. oleh Alexander Fosså, Knut Halvor Smeland, Øystein Fluge, Karl Johan Tronstad, Jon Håvard Loge, Øivind Midttun, Per Magne Ueland, Cecilie Essholt Kiserud

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study

    Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study oleh Kjersti Lia, Rasmus R.K. Jørgensen, Bente L.Wold, Øystein Fluge, Unn-Merete Fagerli, Hanne Bersvendsen, Idun B. Bø, Sameer Bhargava, Alexander Fosså

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

    Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. oleh Ingrid G Rekeland, Kari Sørland, Lisbeth Lykke Neteland, Alexander Fosså, Kine Alme, Kristin Risa, Olav Dahl, Karl J Tronstad, Olav Mella, Øystein Fluge

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group

    Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: result... oleh Elisa J. Pulczynski, Outi Kuittinen, Martin Erlanson, Hans Hagberg, Alexander Fosså, Mikael Eriksson, Marie Nordstrøm, Bjørn Østenstad, Øystein Fluge, Sirpa Leppä, Bente Fiirgaard, Hanne Bersvendsen, Unn-Merete Fagerli

    Diterbitkan 2015-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease

    CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease oleh Sheila K. Pierson, Laura Katz, Reece Williams, Melanie Mumau, Michael Gonzalez, Stacy Guzman, Ayelet Rubenstein, Ana B. Oromendia, Philip Beineke, Alexander Fosså, Frits van Rhee, David C. Fajgenbaum

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients

    T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients oleh Ninja Övergaard, Kjersti Lia, Peter Asdahl, Per Wikman, Ingrid Glimelius, Ingemar Lagerlöf., Ann-Sofie Johansson, Lotta Hansson, Gunilla Enblad, Johan Linderoth, Christina Goldkuhl, Alexander Fosså, Peter Kamper, Daniel Molin

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway

    Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway oleh Knut B. Smeland, Cecilie E. Kiserud, Grete F. Lauritzsen, Unn-Merete Fagerli, Ragnhild S. Falk, Øystein Fluge, Alexander Fosså, Arne Kolstad, Jon H. Loge, Martin Maisenhölder, Stein Kvaløy, Harald Holte

    Diterbitkan 2015-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma.

    Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma. oleh Kaja B Nyquist, Ioannis Panagopoulos, Jim Thorsen, Lisbeth Haugom, Ludmila Gorunova, Bodil Bjerkehagen, Alexander Fosså, Marianne Guriby, Torfinn Nome, Ragnhild A Lothe, Rolf I Skotheim, Sverre Heim, Francesca Micci

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway

    T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway oleh Joshua P. Entrop, Caroline E. Weibull, Karin E. Smedby, Lasse Hjort Jakobsen, Andreas K. øvlisen, Daniel Molin, Ingrid Glimelius, Anna Marklund, Harald Holte, Alexander Fosså, Knut B. Smeland, Tarec Christoffer El-Galaly, Sandra Eloranta

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

    P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) oleh Muhit Ozcan, Yuqin Song, Seung Tae Lee, Felix Mensah, Dipenkumar Modi, Alexander Fossa, Won Seog Kim, Ewa Paszkiewicz-Kozik, Yazeed Sawalha, Omur Gokmen Sevindik, Lalita Norasetthada, Armando Santoro, Kumudu Pathiraja, Samhita Chakraborty, Patricia Marinello, David Lavie

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.

    Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease. oleh Christopher S Nabel, Stephen Sameroff, Dustin Shilling, Daisy Alapat, Jason R Ruth, Mitsuhiro Kawano, Yasuharu Sato, Katie Stone, Signe Spetalen, Federico Valdivieso, Michael D Feldman, Amy Chadburn, Alexander Fosså, Frits van Rhee, W Ian Lipkin, David C Fajgenbaum

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up

    Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up oleh Elisa Jacobsen Pulczynski, Mikkel Runason Simonsen, Outi Kuittinen, Unn-Merete Fagerli, Martin Erlanson, Øystein Fluge, Sirpa Leppä, Bjørn Østenstad, Alexander Fosså, Mikael Eriksson, Tarec El-Galaly, Hanne Kuitunen, Karin Papworth, Maria Ljungqvist, Martin B. Pedersen, Marjukka Pollari

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study

    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study oleh Ingrid G. Rekeland, Alexander Fosså, Asgeir Lande, Irini Ktoridou-Valen, Kari Sørland, Mari Holsen, Karl J. Tronstad, Kristin Risa, Kine Alme, Marte K. Viken, Marte K. Viken, Benedicte A. Lie, Benedicte A. Lie, Olav Dahl, Olav Mella, Olav Mella, Øystein Fluge, Øystein Fluge

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

    A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome oleh Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: